CMPX - CIK 0001738021
The table below shows Compass Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $55.17M | $46.21M | $22.86M | $41.05M | $36.80M | $19.40M |
| Short-term investments | $139.52M | $173.68M | $78.09M | $71.59M | $98.60M | $126.82M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $195.69M |
| $221.12M |
| $106.19M |
| $124.14M |
| $141.14M |
| $153.55M |
| Property, plant & equipment | $169.00K | $119.00K | $131.00K | $231.00K | $493.00K | $592.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $205.17M | $231.26M | $116.70M | $131.45M | $149.15M | $155.61M |
| Accounts payable | $906.00K | $3.10M | $2.60M | $1.58M | $960.00K | $1.19M |
| Total current liabilities | $10.28M | $12.41M | $13.86M | $14.90M | $4.43M | $9.51M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $18.70M | $21.65M | $23.49M | $21.17M | $10.75M | $9.51M |
| Retained earnings | -$449.49M | -$415.46M | -$401.20M | -$381.32M | -$349.65M | -$339.17M |
| Total equity | $186.47M | $209.61M | $93.21M | $110.28M | $138.40M | $146.10M |